Frost & Sullivan Awards EBSCO Information Services for Delivering Innovative Solutions to Access Medical Research Information for Healthcare Providers
SAN ANTONIO, June 7, 2022 /PRNewswire/ -- Based on its recent analysis of the clinical decision support systems (CDSS) industry, Frost & Sullivan recognizes EBSCO Information Services (EBSCO) and specifically its Clinical Decisions products with the 2022 North America Product Leadership Award for delivering forward-thinking products that support evidence-based clinical decision-making and patient engagement. EBSCO is the world's trusted source of information for global institutions, with more than 70 years of addressing the research interests of several academic organizations, libraries, medical institutions, and more. DynaMed® and Dynamic Health™ represent the core resources in EBSCO's Clinical Decisions offerings and are meant to support physicians, advance practice providers, nurses, and allied health professionals.
- EBSCO is the world's trusted source of information for global institutions, with more than 70 years of addressing the research interests of several academic organizations, libraries, medical institutions, and more.
- "EBSCO is a leading provider of CDSS, shared decision making, and medical research solutions, helping improve patient care by arming healthcare professionals with clinical evidence at the point of care," said Pavel Zhebrouski, Best Practices Research analyst at Frost & Sullivan.
- Clinicians can access the EBSCO tool on-the-go, 24 hours a day, with the DynaMed mobile app to boost efficiency and guarantee actionable information.
- EBSCO Information Services Executive Vice President of Clinical Decisions Betsy Jones says that Frost & Sullivan's recognition reflects the company's dedication to making an impact on the healthcare industry.